Medical Device IFU Reprocessing Instructions: Validated, Audit-Ready Guide
Step-by-step guide to writing validated reprocessing instructions for reusable device IFUs, covering cleaning, sterilization, usability, warnings, and audits.
Why IFU Quality Is a Regulatory Flashpoint
Reprocessing instructions are among the most scrutinized sections of any reusable medical device labeling. FDA's 2015 final guidance on reprocessing was triggered in part by highly publicized hospital-acquired infection outbreaks linked to inadequate duodenoscope IFUs. Since then, FDA has consistently treated reprocessing instructions as a submission-acceptance issue — not just a labeling detail. In the EU, notified bodies audit IFU completeness against ISO 17664-1:2021 as a routine part of technical documentation review.
A well-written IFU protects patients, supports regulatory clearance, and reduces post-market complaints. A poorly written one invites Refuse-to-Accept (RTA) decisions, additional information requests, and field safety corrective actions.
This guide covers what to write, how to structure it, how to validate it, and how to prepare it for audit.
Applicable Standards and Regulatory References
| Standard / Regulation | What It Requires |
|---|---|
| ISO 17664-1:2021 | Specifies information manufacturers must provide for processing critical and semi-critical devices |
| ISO 17664-2:2021 | Same as above, for non-critical devices |
| FDA Guidance (March 2015) | Reprocessing Medical Devices in Health Care Settings — validation methods and labeling |
| ISO 20417:2026 | Updated medical device labeling requirements, including measurable IFU readability for lay users |
| ANSI/AAMI ST98:2022 | Cleaning validation standard supporting the IFU cleaning section |
| 21 CFR 801 | General device labeling requirements |
| EU MDR Annex I, Chapter III | Requirements for information supplied with the device |
| Implementing Regulation (EU) 2021/2226 | Electronic IFU (eIFU) requirements, updated by (EU) 2025/1234 for 2026 |
Spaulding Classification: The Starting Point for Every IFU
The Spaulding classification determines the minimum reprocessing method required and should be stated explicitly in the IFU. FDA's 2015 guidance reinforces this as a foundational decision.
| Classification | Definition | Minimum Reprocessing | Example Devices |
|---|---|---|---|
| Critical | Contacts sterile tissue or vascular system | Sterilization required | Surgical instruments, implants, cardiac catheters, arthroscopes |
| Semi-critical | Contacts mucous membranes or non-intact skin | High-level disinfection minimum; sterilization preferred | Endoscopes, laryngoscope blades, respiratory therapy equipment |
| Non-critical | Contacts intact skin only | Low- or intermediate-level disinfection | Stethoscopes, blood pressure cuffs, bedpans, wheelchairs |
The IFU must specify the reprocessing method consistent with the device's Spaulding classification and the validation must support it.
The Six Essential Sections of Reprocessing IFUs
FDA's 2015 guidance and ISO 17664-1 converge on a common set of required information. Below is the recommended structure with detailed content guidance for each section.
Section 1: Device Identification and Scope
Purpose: Ensure the user can confirm they have the correct instructions for their device.
| Required Content | Detail Level |
|---|---|
| Device trade name and model/catalog number | Exact match to device labeling |
| Applicable accessories and components | List all components that require reprocessing |
| Device classification (critical / semi-critical / non-critical) | Per Spaulding classification; drives disinfection/sterilization method |
| Intended reprocessing life (number of cycles) | Must match validation data |
| Contraindications for reuse | Conditions under which the device must not be reprocessed |
Common deficiency: Omitting the maximum number of reprocessing cycles, or stating a number not supported by end-of-life testing.
Section 2: Point-of-Use Treatment
Purpose: Prevent soil from drying on the device before it reaches the reprocessing area.
| Required Content | Example Language |
|---|---|
| Initial action at point of use | "Immediately after use, wipe external surfaces with a damp cloth to remove visible soil." |
| Moisture maintenance | "Keep device moist by covering with a damp towel or placing in a moisture-retaining transport container." |
| Maximum delay before cleaning | "Do not allow soil to dry on the device. Begin cleaning within 60 minutes of use." |
| Disassembly instructions | "Disassemble the device into its three component parts (handle, shaft, tip) by rotating the locking collar counterclockwise." |
| Transport to reprocessing area | "Place disassembled components in a closed, leak-proof container for transport to the decontamination area." |
FDA emphasis: Delays between use and reprocessing create conditions favorable to microbial growth and increase the challenge to subsequent cleaning and disinfection/sterilization steps. The 2015 guidance specifically calls for "prompt, initial cleaning steps and/or measures to prevent the drying of soil."
Section 3: Preparation for Cleaning
| Required Content | Notes |
|---|---|
| Disassembly instructions with illustrations | Show each step; identify components by name |
| Removal of single-use accessories | Specify which parts are discarded, not reprocessed |
| Pre-rinse instructions | Duration, water type, and method |
| Soaking instructions (if applicable) | Solution, concentration, temperature, duration |
Section 4: Cleaning
This section must describe the validated cleaning method — manual, automated, or both.
For Manual Cleaning:
| Element | Content to Include |
|---|---|
| Detergent | Brand name, product name, concentration, and where to obtain |
| Water quality and temperature | E.g., "Reverse osmosis water at 20–40 °C" |
| Soaking | Duration and conditions |
| Brushing | Brush type, size, strokes per surface, direction |
| Lumen flushing | Volume, syringe/flushing device type, number of flushes |
| Rinsing | Volume, water quality, duration |
| Inspection | Visual inspection criteria, lighting requirements |
| Personal protective equipment | PPE requirements for reprocessing personnel |
For Automated Cleaning (Washer-Disinfector):
| Element | Content to Include |
|---|---|
| WD make and model (or compatible class) | Specific validated machine or performance class |
| Cycle program name/number | Exact cycle to select |
| Detergent | Brand, product, concentration, dosing method |
| Rinse aid (if applicable) | Brand, concentration |
| Load configuration | How to arrange instruments in carriers; reference to loading diagram |
| Connection of lumened devices | Adapter type, connection method |
| Post-cycle inspection | Visual inspection after WD cycle completes |
Critical point: If both manual and automated methods are offered, each must have been separately validated. Do not imply that one method is validated based on the other's evidence.
Section 5: Disinfection or Sterilization
Disinfection:
| Element | Content to Include |
|---|---|
| Disinfection method | High-level disinfection (HLD) or intermediate/low-level as justified |
| Agent (if chemical) | Brand name, concentration, contact time, temperature |
| Automated parameters (if thermal WD) | A₀ value, temperature, time |
| Rinsing after chemical disinfection | Volume, method, water quality |
| Drying | Method and duration |
Sterilization:
| Element | Content to Include |
|---|---|
| Sterilization method | Steam, EO, hydrogen peroxide vapor, etc. |
| Cycle parameters | Temperature, exposure time, dry time |
| Packaging | Type, configuration, how to arrange in sterilizer |
| Biological indicator | Type and placement (for validation reference) |
| Sterility Assurance Level (SAL) | Typically 10⁻⁶ |
| Post-sterilization dry time | Duration, conditions |
Section 6: Storage and Reuse
| Element | Content to Include |
|---|---|
| Storage conditions | Temperature, humidity, shelf life after sterilization |
| Packaging integrity check | How to verify before use |
| Reuse life limit | Maximum number of reprocessing cycles; how to track |
| Functional check before use | What the user must verify before each patient use |
| Disposal instructions | When and how to discard the device |
Warnings and Precautions
IFUs must include specific warnings that address foreseeable misuse. Common required warnings:
| Warning Category | Example |
|---|---|
| Incomplete reprocessing risk | "Failure to follow all reprocessing instructions may result in retained organic material or microbial contamination, potentially causing patient infection." |
| Device damage | "Do not use abrasives, wire brushes, or ultrasonic cleaning unless specified. These may damage the device coating." |
| Chemical safety | "Wear appropriate PPE when handling cleaning and disinfecting agents. Refer to agent Safety Data Sheet." |
| Reuse limit | "Do not exceed [X] reprocessing cycles. Device performance beyond this limit has not been validated." |
| Single-use components | "The [component name] is single-use only. Do not reprocess." |
| Compatibility | "Use only the specified cleaning agents and sterilization methods. Use of alternative agents has not been validated." |
| Moisture and corrosion | "Ensure the device is thoroughly dried before storage. Retained moisture may cause corrosion or microbial growth." |
Usability Validation of IFU Instructions
FDA's 2015 guidance recommends that manufacturers validate that users can understand and follow the reprocessing instructions. This is effectively a human factors study for the IFU.
Usability Validation Approach
| Step | Activity |
|---|---|
| 1. Formative evaluation | Have representative users (SPD technicians) attempt to follow draft IFU; observe and document errors, confusion, and deviations |
| 2. Revision | Revise IFU based on formative findings — add illustrations, clarify ambiguous steps, reorganize sequence |
| 3. Summative evaluation | Have a new set of representative users follow the revised IFU under observation; record whether they correctly complete all steps |
| 4. Analysis | Document all use errors and near-misses; assess whether errors are IFU-related or user-related |
| 5. Final revision | Address any remaining IFU-related errors; document rationale for accepted residual risk |
ISO 20417:2026 Readability Requirements
The 2026 update to ISO 20417 introduces measurable readability expectations for IFUs:
"Readily understood" is no longer sufficient as a qualitative claim. Lay-user IFUs must be tested and documented to a defined education level.
Readability scoring: Use validated tools such as Flesch-Kincaid or SMOG; target grade 7–8 equivalent as a benchmark.
Plain-language review: Have the IFU reviewed by someone without a technical background.
Documentation: Record the methodology, results, and iterations made to the IFU as a result of readability testing.
IFU Content Checklist: Audit-Ready Template
Use this checklist to verify completeness before submission or audit.
| # | IFU Element | Present? | Validated? | Location in IFU |
|---|---|---|---|---|
| 1 | Device identification (name, model, catalog number) | ☐ | N/A | |
| 2 | Intended reprocessing life (max cycles) | ☐ | ☐ End-of-life testing | |
| 3 | Point-of-use treatment instructions | ☐ | ☐ Cleaning validation | |
| 4 | Disassembly instructions with diagrams | ☐ | ☐ Usability validation | |
| 5 | Preparation for cleaning (pre-rinse, soaking) | ☐ | ☐ Cleaning validation | |
| 6 | Manual cleaning procedure (detergent, water, brushing, rinsing) | ☐ | ☐ Cleaning validation (ST98) | |
| 7 | Automated cleaning procedure (WD cycle, detergent, loading) | ☐ | ☐ Cleaning validation + ISO 15883 | |
| 8 | Visual inspection criteria and method | ☐ | ☐ Cleaning validation | |
| 9 | Disinfection method and parameters | ☐ | ☐ Disinfection validation | |
| 10 | Sterilization method and parameters | ☐ | ☐ Sterilization validation | |
| 11 | Packaging instructions for sterilization | ☐ | ☐ Packaging validation | |
| 12 | Drying instructions and duration | ☐ | ☐ Validation | |
| 13 | Storage conditions and shelf life | ☐ | ☐ Stability/aging data | |
| 14 | Functional check before reuse | ☐ | ☐ End-of-life testing | |
| 15 | Reuse life tracking method | ☐ | N/A | |
| 16 | Disposal instructions | ☐ | N/A | |
| 17 | Warnings and precautions | ☐ | ☐ Risk management file | |
| 18 | PPE requirements for reprocessing personnel | ☐ | N/A | |
| 19 | Contact information for questions | ☐ | N/A | |
| 20 | Applicable standards referenced | ☐ | N/A |
Submission Evidence Mapping
| Submission Document | IFU Evidence Required |
|---|---|
| 510(k) | Complete proposed labeling including reprocessing IFU; validation summary or full report per Appendix E of FDA guidance |
| PMA | Full reprocessing validation protocol and test report; IFU usability validation report |
| De Novo | Same as PMA |
| EU MDR Technical File (Annex II) | Full IFU; reprocessing validation reports; risk management file linking IFU content to risk controls |
| Design History File | IFU design inputs, outputs, verification records, usability testing records |
FDA Appendix E devices (for which 510(k) must contain data to validate reprocessing instructions) include:
Endoscopes and accessories
Laparoscopic instruments and accessories
Arthroscopic instruments and accessories
Devices with lumens
Devices with hinges or moving parts
Ultrasonic surgical aspirators
Phacoemulsification devices
Common Audit Findings and How to Prevent Them
| Audit Finding | Root Cause | Prevention |
|---|---|---|
| IFU references unavailable agents | Detergent/disinfectant not available in target market | Verify agent availability; list alternatives with validation support |
| Missing maximum reprocessing cycles | Not tested or not stated | Include validated cycle limit; support with end-of-life data |
| No usability validation of IFU | Assumed clarity without testing | Conduct formative and summative evaluations per FDA guidance |
| Cleaning validation does not match IFU | Protocol used different parameters than IFU text | Side-by-side comparison of IFU text and validation protocol |
| No point-of-use treatment section | Omitted as "not necessary" | Include even if brief; regulators expect to see it addressed |
| Missing diagrams for disassembly | Text-only instructions for complex devices | Add numbered step-by-step diagrams with labeled components |
| IFU not in required language(s) | Overlooked EU language requirements | ISO 17664 requires IFU in accepted languages of member states where sold |
| eIFU non-compliant with EU MDR | Missing paper backup option or URL stability | Implement (EU) 2025/1234 requirements; register in EUDAMED by May 2026 |
Electronic IFU (eIFU) Considerations
Under EU MDR and Implementing Regulation (EU) 2025/1234 (effective for 2026):
| Requirement | Detail |
|---|---|
| Scope expansion | Nearly all professionally used devices may use eIFU without printed manuals, based on risk assessment |
| Mandatory paper option | Printed IFU must be available free of charge, supplied within 7 days upon request |
| Lay-user devices | Home-use and consumer devices must still include printed IFU by default |
| Persistent URLs | Packaging must include stable link to eIFU; link must remain accessible for device lifecycle |
| EUDAMED registration | By May 28, 2026, manufacturers must register UDI and eIFU links in EUDAMED |
| Version control | Complete archive of all prior IFU versions with traceability, timestamps, and change history |
Key Takeaways
Reprocessing IFUs must follow a six-section structure: identification, point-of-use treatment, preparation, cleaning, disinfection/sterilization, and storage/reuse
Every instruction must be validated — the IFU text must match the validation protocol parameters exactly
FDA expects IFU usability validation — a human-factors-like study confirming that users can follow the instructions
ISO 20417:2026 introduces measurable readability requirements — qualitative "readily understood" claims are no longer sufficient
Warnings and precautions must address foreseeable misuse, supported by the risk management file
Point-of-use treatment is expected even for simple devices; omitting it is a common audit finding
eIFU compliance in the EU requires EUDAMED registration by May 2026 and persistent URL management
Use the audit-ready checklist above to verify completeness before every submission
Sources
ISO 17664-1:2021 — Processing of health care products, Part 1: Critical and semi-critical medical devices
ISO 17664-2:2021 — Processing of health care products, Part 2: Non-critical medical devices
FDA Guidance — Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling (March 2015)
ISO 20417:2026 — Medical device labeling requirements
ANSI/AAMI ST98:2022 — Cleaning validation of health care products
Implementing Regulation (EU) 2025/1234 — Electronic instructions for use
Emergo by UL — US FDA Reprocessing Expectations (March 2026)
Test Labs UK — Medical Device Reprocessing Instructions Development
DDISmart — Electronic Instructions for Use (eIFU): The Complete 2026 Guide
TÜV SÜD — Reprocessing Validation for Reusable Medical Devices (whitepaper)
Nelson Labs — Comments on Reprocessing Guidance for Industry and FDA Staff (March 2015)
MDX CRO — ISO 20417:2026: Medical Device Labelling Requirements